ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,687Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 807

$406K Total Retail Price of All Prescriptions

Rank: 209 out of 807

492 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 492 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 492 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 8,684 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LISINOPRIL 752 695 1 2
SIMVASTATIN 726 652 2 1
OMEPRAZOLE 411 360 3 4
FUROSEMIDE 349 315 4 6
LEVOTHYROXINE SODIUM 291 277 5 3
AMLODIPINE BESYLATE 272 258 6 5
ATENOLOL 263 238 7 7
WARFARIN SODIUM 260 240 8 10
ATORVASTATIN CALCIUM 241 219 9 11
HYDROCHLOROTHIAZIDE 226 218 10 9
METOPROLOL TARTRATE 187 162 11 8
HYDROCODONE-ACETAMINOPHEN 177 156 S3 12 15
POTASSIUM CHLORIDE 138 130 13 18
ZOLPIDEM TARTRATE 137 104 14 23
METOPROLOL SUCCINATE 136 124 15 13
METFORMIN HCL 120 108 16 12
CITALOPRAM HBR 117 110 17 17
GABAPENTIN 112 110 18 16
VENLAFAXINE HCL ER 101 66 19 91
LOSARTAN POTASSIUM 100 95 20 14
TAMSULOSIN HCL 99 95 21 27
ALLOPURINOL 97 86 22 26
ADVAIR DISKUS 91 80 23 33
PREDNISONE 90 87 24 24
TRAZODONE HCL 89 75 25 25
CLONIDINE HCL 83 83 26 82
DIGOXIN 82 81 27 41
PRAVASTATIN SODIUM 80 64 28 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 70 29 28
ALENDRONATE SODIUM 77 77 30 20
DILTIAZEM ER 76 76 31 109
FLUTICASONE PROPIONATE 70 66 32 30
TRAMADOL HCL 68 68 33 19
CELEBREX 65 62 34 87
PAROXETINE HCL 65 48 34 49
DIOVAN 62 62 36 46
DILTIAZEM 24HR ER 59 57 37 189
NAPROXEN 58 40 38 112
PRAMIPEXOLE DIHYDROCHLORIDE 51 30 39 121
DILTIAZEM 24HR CD 50 50 40 76
CARVEDILOL 50 50 40 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.